OpenEye: Opportunity Pharma and OpenEye join forces to develop AI expert for drug discovery
Drug discovery will benefit from a virtual artificial intelligence (AI) expert thanks to Opportunity Pharma and OpenEye, Cadence Molecular Sciences joining forces.
Read full article »
OpenEye is a New Mexico-based SaaS platform that offers molecular modeling solutions for pharmaceutical and biotechnology companies.
Read more